Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001325812-10-000003
Filing Date
2010-06-03
Accepted
2010-06-03 16:53:52
Documents
2
Period of Report
2010-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 2841
2 EDGAR SUPPORTING DOCUMENT reid_060110poa.txt EX-24 3994
  Complete submission text file 0001325812-10-000003.txt   8623
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Reid Laurence (Reporting) CIK: 0001492749 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50743 | Film No.: 10876494